---
category: news
title: "UK start-up raises £14mn to develop AI-boosted adaptable vaccines"
excerpt: "Other companies using AI to design vaccines include BioNTech, supported by its £562mn acquisition of UK start-up InstaDeep; Cambridge-based DIOSynVax, which also builds synthetic antigens using computational modelling; and Evaxion, a Danish biotech in which MSD GHIF is also an investor."
publishedDateTime: 2024-02-26T05:00:00Z
originalUrl: "https://www.ft.com/content/b2a6fdad-7dc7-414c-a63b-26705af788bc?shareType=nongift"
webUrl: "https://www.ft.com/content/b2a6fdad-7dc7-414c-a63b-26705af788bc?shareType=nongift"
type: article
quality: 17
heat: 17
published: false

provider:
  name: The Financial Times
  domain: ft.com

topics:
  - AI

secured: "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;oovdVtC2y27AUdJOO7T1/Q=="
---

